Results
eNauka >
Results >
A double blind placebo-controlled randomized phase III study of high dose continuous infusion cytosine arabinoside (araC) with or without cloretazine (R) in patients with first relapse of acute myeloid leukemia (AML).
| Title: | A double blind placebo-controlled randomized phase III study of high dose continuous infusion cytosine arabinoside (araC) with or without cloretazine (R) in patients with first relapse of acute myeloid leukemia (AML). | Authors: | Giles, Francis J; Stock, Wendy; Vey, Norbert; Sciter, Karen; DeAngelo, Daniel J; Boskovic, Darinka V; Stuart, Robert K; Johnson, Bonny; Cahill, Ann L; O'Brien, Susan | Issue Date: | 2006 | Publication: | BLOOD | ISSN: | 0006-4971 Blood Search Idenfier |
Type: | Conference Paper | Collation: | vol. 108 br. 11 str. 1970-1970 | DOI: | 10.1182/blood.V108.11.1970.1970 | WoS-ID: | 000242440002488 | URI: | https://enauka.gov.rs/handle/123456789/797844 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.